Cipla Q1 FY25 results: Net profit up 25% at Rs 988 crore, revenue rises 9%

Q: How long will it take to read this news story?

The story "Cipla Q1 FY25 results: Net profit up 25% at Rs 988 crore, revenue rises 9%" has 524 words across 26 sentences, which will take approximately 3 - 5 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Cipla Q1 FY25 results: Net profit up 25% at Rs 988 crore, revenue rises 9%" was covered 5 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 255 news stories per day. It's most recent story was published 3 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #21783085</li><li>URL: https://beamstart.com/news/cipla-q1-fy25-results-net-17219898747761</li></ul>

Business Standard Logo Business Standard 5h ago

Cipla Q1 FY25 results: Net profit up 25% at Rs 988 crore, revenue rises 9% - Business Standard

Quick Summary:

On a sequential basis, the company exhibited a 5.67 per cent increase in revenue, along with PAT, which also rose by 18.28 per cent, Cipla stock was up 5.

The proportion of chronic treatments in the portfolio increased by 1.06 percentage points year-over-year to 61.5 per cent.

The company invested Rs 353 crore in research and development, constituting 5.3 per cent of sales, reflecting a year-on-year increase of 1 per cent.